Lipoprotein Corona Fingerprints: Implications for Pulmonary Clearance and Toxicity of Engineered Nanoparticles

脂蛋白电晕指纹:对工程纳米粒子的肺部清除和毒性的影响

基本信息

项目摘要

 DESCRIPTION (provided by applicant) Human exposures to industrially relevant engineered nanomaterials (ENMs) are increasing in occupational and environmental settings. Inhalation is a major route of entry. Airborne nanoparticles (NPs) reach the deep alveolar region of the lung where they encounter biomolecules of the alveolar lining fluid. The interaction results in the formation of a phospholipid-protein "corona" on the NP surface. The very first step in this encounter is underappreciated and poorly characterized, but is critical in determining subsequent fate and effects of NPs. The investigators preliminary data show that NPs of different chemical composition develop a characteristic phospholipid-protein corona while interacting with biomolecules of lung lining fluid. They also found the pulmonary responses and lung clearance profiles for these diverse NPs to be dramatically different. With the rapidly expanding field of nanotechnology, hundreds of novel NPs exhibiting diverse physicochemical properties are being generated. It would be practically impossible and prohibitively expensive to evaluate toxicity of all of them individually as every change in NP chemistry, charge, size, or shape constitutes a potentially new material requiring toxicological study. Therefore, there is an urgent unmet need for developing high-throughput screening assays for predicting pulmonary clearance and toxicity of NPs. This comprehensive study will identify and connect phospholipid-protein corona profiles to particokinetic and toxicological endpoints. The investigators propose to examine the independent and collective effects of the six major proteins and six phospholipids of lung lining fluid on the uptake of NPs by cells such as macrophages and their subsequent responses. They will also evaluate the role of the phospholipid-protein corona in modulating translocation of NPs across the air blood barrier. Additionally, the investigators propose molecular dynamic simulation studies for understanding the nature of NP-biomolecular interactions in alveoli. They will test the effects of varying physicochemical properties such as size, shape and surface functionalization on the corona composition. They will create a phospholipid-protein corona profile database library that integrates corona analyses with molecular dynamic simulation data. While the project builds on extant work in the field, it is unique (a search of NIH Reporter and PubMed does not reveal any similar efforts that use comprehensive corona profiling to predict nanotoxicity) and addresses an important need. This transformative study takes advantage of phospholipid-protein corona profiling to create a high-throughput predictive nanotoxicity model that identifies critical factors controlling NP toxicity. The proposed research will enable systematic risk assessment and classification of nanomaterials based on their corona profiles in addition to other parameters used to group nanomaterials such as their size, physicochemical features, biopersistence and acute toxicity. Further, the study will enable in prevention of the adverse effects of nanomaterials and their use in nanotechnology.
 描述(由申请人提供) 在职业和环境环境中,人类对工业相关工程纳米材料 (ENM) 的接触不断增加。吸入是空气中的纳米粒子 (NP) 进入肺泡深处并与肺泡内层液体的生物分子相互作用的主要途径。导致在 NP 表面形成磷脂蛋白“冠”。这种遭遇的第一步并未得到充分重视,也没有得到很好的表征,但对于决定后续的命运至关重要。研究人员的初步数据表明,不同化学物质的纳米粒子在与肺内壁液体的生物分子相互作用时会形成特征性的磷脂蛋白冠,他们还发现这些不同的纳米粒子的肺部反应和肺清除率显着不同。随着纳米技术领域的迅速扩展,数百种具有不同物理化学性质的新型纳米粒子正在产生,因为纳米粒子化学、电荷、化学性质的每一次变化,单独评估所有这些纳米粒子的毒性实际上是不可能的,而且成本高昂。因此,迫切需要开发高通量筛选方法来预测 NP 的肺部清除率和毒性。这项综合研究将识别磷脂-蛋白冠谱并将其与它们联系起来。研究人员建议检查肺衬液中六种主要蛋白质和六种磷脂对巨噬细胞等细胞摄取纳米粒子及其随后反应的独立和集体影响。他们还将评估磷脂-蛋白质冠在调节纳米粒子穿过气血屏障的易位中的作用,此外,研究人员提出了分子动力学模拟研究,以了解肺泡中纳米粒子-生物分子相互作用的性质。他们将创建一个磷脂-蛋白质电晕谱数据库,该数据库将电晕分析与分子动态模拟数据结合起来。与该领域的现有工作相比,它是独一无二的(对 NIH Reporter 和 PubMed 的搜索没有发现任何使用综合电晕分析来预测纳米毒性的类似努力),并且这项变革性研究利用磷脂-蛋白质电晕分析来解决一个重要需求。创建一个高通量预测纳米毒性模型,该模型可识别控制纳米颗粒毒性的关键因素。除了用于对纳米材料进行分组的其他参数外,拟议的研究还将根据其电晕分布对纳米材料进行系统的风险评估和分类。此外,该研究还将有助于预防纳米材料及其在纳米技术中的应用的不利影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nagarjun Konduru Venkata其他文献

Nagarjun Konduru Venkata的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nagarjun Konduru Venkata', 18)}}的其他基金

Lipoprotein Corona Fingerprints: Implications for Pulmonary Clearance and Toxicity of Engineered Nanoparticles
脂蛋白电晕指纹:对工程纳米粒子的肺部清除和毒性的影响
  • 批准号:
    9329451
  • 财政年份:
    2016
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似国自然基金

儿童药品不良反应主动监测中时序处理策略的方法学研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
  • 批准号:
    82274368
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
  • 批准号:
    82273739
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 24.9万
  • 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
  • 批准号:
    10596013
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
  • 批准号:
    10674401
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
  • 批准号:
    10735117
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
Mechanisms of Sleep Regulation in C. elegans
线虫睡眠调节机制
  • 批准号:
    10711702
  • 财政年份:
    2023
  • 资助金额:
    $ 24.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了